September 6, 2017 by Bill Schiffner
Bob Moran, Bryan Everett, Frank Vitrano, GNC Holdings, John Standley, Ken Martindale, Michael Hines, Rite Aid, Rite Aid Foundation
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. president and CEO of stores Ken Martindale is leaving the company to become chief executive officer of GNC Holdings Inc. Rite Aid said Wednesday that with Martindale’s departure, Bryan Everett, currently executive vice president in charge of store operations, has been named chief operating officer of Rite Aid
August 19, 2017 by Chain Drug Review
John Standley, Rite Aid, Walgreens, Walgreens Boots Alliance, Wellness Stores
2017, Issue 08-21-2017, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. envisions a smaller but better-performing store base following the expected closing of its deal to sell nearly half its stores to Walgreens Boots Alliance Inc. (WBA). In a recent filing with the Securities and Exchange Commission, Rite Aid provided a more detailed picture of its store base after
August 7, 2017 by Greg Jacobson and Chain Drug Review
Fred's, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 08-07-2017, Issues, News
NEW YORK — With the acquisition of Rite Aid Corp. by Walgreens Boots Alliance Inc. (WBA) now canceled and replaced by a smaller transaction, the chain drug landscape will retain a more familiar look. Nonetheless, all three parties to the original deal, which involved the purchase of 865 Rite Aid locations by Fred’s Inc., will
August 1, 2017 by Chain Drug Review
John Standley, Rite Aid, Walgreens Boots Alliance, Wellness Store
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. has provided a more detailed picture of its store base after the expected closing of its deal to sell nearly half its stores to Walgreens Boots Alliance (WBA). In a filing with the Securities and Exchange Commission, Rite Aid said it would have 2,336 stores following the sale
July 31, 2017 by CDR Blog and Chain Drug Review
EnvisionRx, EnvisionRxOptions, Health Dialog, John Standley, RediClinic, Rite Aid, Rite Aid Health Alliance, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Investments made in recent years put Rite Aid in a better position to rebound from the terminated deal to be acquired by Walgreens Boots Alliance. Rite Aid’s acquisitions of retail clinic operator RediClinic, health care management specialist Health Dialog and pharmacy benefit manager EnvisionRx give it more options as its leadership considers the company’s future
June 9, 2017 by Chain Drug Review
Capital Forum, Federal Trade Commission, Fred's, John Standley, Ken Martindale, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
NEW YORK — The Federal Trade Commission is readying a lawsuit to block the Walgreens-Rite Aid merger deal, according to published reports. Citing policy news service Capital Forum, which analyzes the antitrust review of mergers and acquisitions, Investors Business Daily said on Friday that the FTC was “preparing advice” to take action against the transaction,
June 7, 2017 by Chain Drug Review
Fred's, John Standley, Ken Martindale, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — In a memo to employees this week, Rite Aid Corp.’s top executives appear to acknowledge that the company’s acquisition by Walgreens Boots Alliance (WBA) may not be cleared by the Federal Trade Commission. “We remain actively engaged in discussions with the FTC to attempt to gain regulatory approval, and there can be
June 5, 2017 by Geoff Walden and Chain Drug Review
Federal Trade Commission, Fred's, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 06-05-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has taken action to force the hand of federal regulators deciding whether to approve its pending acquisition of Rite Aid Corp. WBA and Rite Aid last month notified the Federal Trade Commission that they have complied with the agency’s second request for information on the deal. While
May 9, 2017 by Chain Drug Review
John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill., and CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) and Rite Aid Corp. said they have met the Federal Trade Commission’s second request for information on their planned merger. Late Monday, WBA and Rite Aid announced that they have “certified substantial compliance,” meaning that they have provided the information needed to determine if
April 25, 2017 by Chain Drug Review
EnvisionRx, John Standley, RediClinic, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Despite declines in net income, Rite Aid Corp. posted increased sales and exceeded Wall Street’s adjusted earnings per share forecast for its fiscal 2017 fourth quarter and year. Chairman and chief executive officer John Standley, however, noted that the ongoing regulatory review of Rite Aid’s deal to be acquired by Walgreens
February 6, 2017 by Scot Meyer and Chain Drug Review
Dedra Castle, John Standley, Ken Black, Rite Aid
2017, Issue 02-06-2017, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. has promoted Ken Black to senior vice president and chief human resources officer. He succeeds Dedra Castle, who is leaving the company for personal health reasons. “On behalf of the entire Rite Aid team, I thank Dedra for her many significant contributions to our company,” Rite Aid chairman
January 16, 2017 by David Pinto and Chain Drug Review
Albertsons, America’s drug chains, Bob Miller, CVS Health, David Pinto, Doug McMillon, George Riedl, Helena Foulkes, John Standley, Larry Merlo, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walmart
2017, Issue 01-16-2017, Issues, Opinion
Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.
January 2, 2017 by Jeffrey Woldt and Chain Drug Review
Fred's, Jeffrey Woldt, John Standley, Ken Martindale, Mike Bloom, Rite Aid, sale of the Rite Aid stores to Fred’s, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, Opinion
The agreement struck last month for the sale of 865 Rite Aid Corp. drug stores to Fred’s Inc. is a momentous development for those companies, as well as Walgreens Boots Alliance, which after 14 months is still working to finalize the acquisition of Rite Aid. The $950 million all-cash deal will bring Fred’s stores and
December 22, 2016 by Chain Drug Review
John Standley, Rite Aid, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. said slim reimbursement rates, new generic drugs and the ongoing antitrust talks for the merger with Walgreens Boots Alliance (WBA) squeezed sales and earnings for its fiscal 2017 third quarter. Rite Aid said Thursday that for the third quarter ended Nov. 26, sales dipped 0.8% to $8.09 billion